Dose intensification and breast cancer: current results and future perspectives.
Antoine
E C
EC
Department of Medical Oncology, Hôpital de la Salpétrière, Paris, France.
Khayat
D
D
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005544:Forecasting; D006801:Humans; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D015996:Survival Rate
D000970:Antineoplastic Agents